Anavex Life Sciences (AVXL) Assets Growth (1y) (2012 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.21% |
| Sep 30, 2025 | -23.42% |
| Jun 30, 2025 | -27.63% |
| Mar 31, 2025 | -18.94% |
| Dec 31, 2024 | -16.23% |
| Sep 30, 2024 | -12.19% |
| Jun 30, 2024 | -10.31% |
| Mar 31, 2024 | -9.22% |
| Dec 31, 2023 | -0.20% |
| Sep 30, 2023 | 1.10% |
| Jun 30, 2023 | -1.50% |
| Mar 31, 2023 | -0.68% |
| Dec 31, 2022 | -5.43% |
| Sep 30, 2022 | -5.51% |
| Jun 30, 2022 | -3.72% |
| Mar 31, 2022 | 91.78% |
| Dec 31, 2021 | 188.76% |
| Sep 30, 2021 | 367.88% |
| Jun 30, 2021 | 426.14% |
| Mar 31, 2021 | 169.42% |
| Dec 31, 2020 | 72.91% |
| Sep 30, 2020 | 36.37% |
| Jun 30, 2020 | 43.98% |
| Mar 31, 2020 | 50.95% |
| Dec 31, 2019 | 42.22% |
| Sep 30, 2019 | -3.35% |
| Jun 30, 2019 | -18.01% |
| Mar 31, 2019 | -20.64% |
| Dec 31, 2018 | -22.04% |
| Sep 30, 2018 | -5.86% |
| Jun 30, 2018 | 7.58% |
| Sep 30, 2017 | 193.08% |
| Jun 30, 2015 | -14.33% |
| Mar 31, 2015 | -38.17% |
| Dec 31, 2014 | 4,572.70% |
| Sep 30, 2014 | 1,768.98% |
| Jun 30, 2014 | 267,541.26% |
| Mar 31, 2014 | 2,113,353.80% |
| Dec 31, 2013 | 88.84% |
| Sep 30, 2013 | 2,891.33% |
| Jun 30, 2013 | -84.28% |
| Mar 31, 2013 | -99.75% |
| Sep 30, 2012 | -93.52% |